
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
Philipp Busenhart, Ana Montalban‐Arques, Egle Katkeviciutė, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003465-e003465
Open Access | Times Cited: 41
Philipp Busenhart, Ana Montalban‐Arques, Egle Katkeviciutė, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003465-e003465
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer
Yosui Nojima, Ryoji Yao, Takashi Suzuki
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167693-167693
Closed Access | Times Cited: 2
Yosui Nojima, Ryoji Yao, Takashi Suzuki
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167693-167693
Closed Access | Times Cited: 2
Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications
Ute Reuning, Vincenzo Maria D’Amore, Kairbaan Hodivala‐Dilke, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108193-108193
Closed Access | Times Cited: 1
Ute Reuning, Vincenzo Maria D’Amore, Kairbaan Hodivala‐Dilke, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108193-108193
Closed Access | Times Cited: 1
The aryl hydrocarbon receptor controls IFN-γ-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma
Megan Snyder, Zhongyan Wang, Brian Lara, et al.
The Journal of Immunology (2025)
Open Access | Times Cited: 1
Megan Snyder, Zhongyan Wang, Brian Lara, et al.
The Journal of Immunology (2025)
Open Access | Times Cited: 1
The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology
Qingfang Zhang, Shuo Zhang, Jianrui Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6170-6170
Open Access | Times Cited: 22
Qingfang Zhang, Shuo Zhang, Jianrui Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6170-6170
Open Access | Times Cited: 22
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration
Caihua Zhang, Kang Li, Hongzhang Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Caihua Zhang, Kang Li, Hongzhang Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
Ewa Brzozowska, Sameer Deshmukh
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12346-12346
Open Access | Times Cited: 24
Ewa Brzozowska, Sameer Deshmukh
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12346-12346
Open Access | Times Cited: 24
68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism
Serkan Kuyumcu, Dilara Denizmen, Duygu Has Şimşek, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3912-3923
Open Access | Times Cited: 5
Serkan Kuyumcu, Dilara Denizmen, Duygu Has Şimşek, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3912-3923
Open Access | Times Cited: 5
Targeting integrins in drug‐resistant acute myeloid leukaemia
Heather Ogana, Samantha Hurwitz, Nathan Wei, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 295-316
Open Access | Times Cited: 13
Heather Ogana, Samantha Hurwitz, Nathan Wei, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 295-316
Open Access | Times Cited: 13
Genome-wide associations with longevity and reproductive traits in U.S. rangeland ewes
Jamin Smitchger, J. B. Taylor, Michelle R. Mousel, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
Jamin Smitchger, J. B. Taylor, Michelle R. Mousel, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
Zhe Zhang, Zheng Wang, Tong Liu, et al.
APOPTOSIS (2023) Vol. 29, Iss. 5-6, pp. 570-585
Closed Access | Times Cited: 11
Zhe Zhang, Zheng Wang, Tong Liu, et al.
APOPTOSIS (2023) Vol. 29, Iss. 5-6, pp. 570-585
Closed Access | Times Cited: 11
Overcoming Immune Checkpoint Inhibitor Resistance via Potent and Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
Anna Lechner, Peter A. Jordan, Gabriella Costa Machado da Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Anna Lechner, Peter A. Jordan, Gabriella Costa Machado da Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
A Review of Talin- and Integrin-Dependent Molecular Mechanisms in Cancer Invasion and Metastasis
Zbigniew Baster, L.F. Russell, Zenon Rajfur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1798-1798
Open Access
Zbigniew Baster, L.F. Russell, Zenon Rajfur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1798-1798
Open Access
Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv
Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis
Jing He, Yan Gao, Linyuan Jing, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jing He, Yan Gao, Linyuan Jing, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance
Allan M. Johansen, Steven D. Forsythe, Callum McGrath, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3676-3687
Closed Access | Times Cited: 3
Allan M. Johansen, Steven D. Forsythe, Callum McGrath, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3676-3687
Closed Access | Times Cited: 3
The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment
Chi Yu, Wei Jiang, Bin Li, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 7
Chi Yu, Wei Jiang, Bin Li, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 7
The integrin adhesome and control of anti-tumour immunity
Emily R. Webb, Annabel Black, Nicole D. Barth, et al.
Biochemical Society Transactions (2024)
Closed Access | Times Cited: 2
Emily R. Webb, Annabel Black, Nicole D. Barth, et al.
Biochemical Society Transactions (2024)
Closed Access | Times Cited: 2
Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway
Feng Xiang, Xianling Liu, Juanjuan Xiang, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2520-2537
Open Access | Times Cited: 6
Feng Xiang, Xianling Liu, Juanjuan Xiang, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2520-2537
Open Access | Times Cited: 6
Acidity-induced ITGB6 promote migration and invasion of lung cancer cells by epithelial-mesenchymal transition and focal adhesion
Linxin Liu, Zhuoru He, Zhangyu Jiang, et al.
Experimental Cell Research (2024) Vol. 436, Iss. 1, pp. 113962-113962
Closed Access | Times Cited: 2
Linxin Liu, Zhuoru He, Zhangyu Jiang, et al.
Experimental Cell Research (2024) Vol. 436, Iss. 1, pp. 113962-113962
Closed Access | Times Cited: 2
Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
Yunyu Lian, Silüe Zeng, Sai Wen, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 5
Yunyu Lian, Silüe Zeng, Sai Wen, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 5
DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma
Dandan Zhu, Huolun Feng, Zhixiong Zhang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Dandan Zhu, Huolun Feng, Zhixiong Zhang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Yong-song Yong, Richard Demmler, Bisan Abdalfatah Zohud, et al.
The Journal of Pathology (2024)
Open Access | Times Cited: 1